Orthofix International reported $-18.9M in EBIT for its fiscal quarter ending in September of 2024.





Ebit Change Date
Accuray USD 11.38M 12.71M Sep/2024
AngioDynamics USD -4.05M 1.54M Feb/2025
AtriCure USD 2.49M 2.28M Dec/2025
Dexcom USD 323M 80.5M Dec/2025
EDAP TMS EUR -4.92M 843K Sep/2025
Globus Medical USD 181.31M 298.83M Dec/2025
Hologic USD 240.9M 12.1M Dec/2025
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 66M 54.24M Dec/2025
J&J USD 5.11B 2.3B Dec/2025
Medtronic USD 1.74B 40M Dec/2025
Mesa Laboratories USD 4.45M 2.5M Sep/2024
Orthofix International USD -18.9M 6.01M Sep/2024
Smith & Nephew USD 440M 50M Dec/2025
STAAR Surgical USD -10.93M 35.38M Dec/2025
Stryker USD 1.97B 609M Dec/2025
Surmodics USD -322K 2.13M Dec/2023
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 36.34M 76.31M Dec/2025
Veracyte USD 24.63M 1.52M Dec/2025
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025